Texas Gov. Greg Abbott on Monday announced his state has obtained its own supply of monoclonal antibodies, a type of treatment for COVID-19, in a move that bypasses the Biden administration’s limits. “Texas has obtained its own separate allocation of these monoclonal antibody treatments working around the limitations that President Biden has put on us so…
Texas Acquires COVID-19 Monoclonal Antibodies, Bypassing Biden HHS Limits: Governor
September 29, 2021
admin
AMERICACCP VirusGreg AbbottHealth NewsLocal NewsMind & BodyRegional-Local NewsTexasUSUS NewsVaccines & Safety
0 Comment
3 Shots Will Be ‘Optimal Regimen’ of COVID-19 Vaccination: Fauci
Practically everybody will be directed in the future to get a booster dose of a COVID-19 vaccine, Dr. Anthony Fauci signaled on Tuesday. “Ultimately I believe that the optimal regimen for the vaccine for the mRNAs is going to include that third booster shot,” Fauci, the director of the National Institute of Allergy and Infectious Diseases,…
COVID-19 Vaccine Should Not Be Mandated for Children: Dr. Scott Atlas
September 29, 2021
admin
AMERICACCP VirusCOVID-19Dr. Scott AtlasHealth NewsMind & BodyPUBLIC HEALTH INFORMATIONUSUS NewsVaccineVaccines & Safety
0 Comment
The COVID-19 vaccine should not be mandated for children since it does not “necessarily benefit” them like the vaccines required for school and child care, according to former White House COVID-19 adviser Dr. Scott Atlas. “Those vaccines that are mandated for children, even if you believe they should be mandated, are for diseases that are…
Delaware Mandates COVID-19 Vaccination for Teachers
Delaware teachers and other school staffers must get a COVID-19 vaccine or undergo weekly testing. Gov. John Carney, a Democrat, and state health and education officials announced the mandate on Tuesday. The requirement will be formally laid out in an emergency regulation and is slated to take effect Nov. 1. It applies to over 12,000…
GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
GlaxoSmithKline PLC (GSK) said on Tuesday it would develop an HIV treatment with Japan’s Shionogi for use in regimens with dosing gaps of three months or more, as the drugmaker seeks to build on the success of its previous long-acting therapies. The British firm said it would pay Shionogi 20 million pounds ($27.36 million) upfront,…
CDC Director: Loss of Unvaccinated Healthcare Workers Is a ‘Challenge’
Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said COVID-19 vaccine mandates for healthcare workers will likely create staff shortages around the United States, coming as some hospital CEOs have issued warnings. “We have seen that these vaccine mandates get more people vaccinated,” Walensky said during a “Good Morning America” appearance on Monday. “It absolutely…
CDC Director: Loss of Unvaccinated Health Care Workers Is a ‘Challenge’
Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said COVID-19 vaccine mandates for health care workers will likely create staff shortages around the United States, echoing the recent warnings of some hospital chief executives. “We have seen that these vaccine mandates get more people vaccinated,” Walensky said during a “Good Morning America”…
Pfizer CEO Predicts Annual COVID-19 Vaccinations
People will end up needing an annual COVID-19 shot, Pfizer’s CEO predicts. Moderna’s CEO Stéphane Bancel said last week he believes the COVID-19 pandemic will end next year. He said more and more people will get a COVID-19 vaccine and those who don’t will gain natural immunity, or protection against infection from contracting the disease and…
Pfizer’s Israel ‘Experiment’ Reveals Likely Future
A Pfizer executive has described Israel as a unique “laboratory” to assess COVID jab effects, saying whatever happens there can reliably be expected to happen elsewhere, months later. Israel’s N12 News obtained a recording of a Zoom meeting with academics in which a Pfizer vice president and its chief scientist, Dr. Philip Dormitizer, discussed the…
Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued
News Analysis Data on the effectiveness of convalescent plasma for hospitalized COVID-19 patients is still inconclusive despite more than a year since the federal authority first issued an emergency use authorization (EUA) for the therapy and many studies have been conducted. Findings from a recent randomized controlled trial suggest that convalescent plasma—the liquid component of…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta